Provided by Tiger Trade Technology Pte. Ltd.

Owens-Corning

117.20
+2.522.20%
Post-market: 117.200.00000.00%19:30 EDT
Volume:1.14M
Turnover:133.46M
Market Cap:9.26B
PE:-14.24
High:117.77
Open:113.39
Low:113.00
Close:114.68
52wk High:159.91
52wk Low:97.53
Shares:79.05M
Float Shares:78.15M
Volume Ratio:0.80
T/O Rate:1.46%
Dividend:3.06
Dividend Rate:2.61%
EPS(TTM):-8.2304
EPS(LYR):-6.2200
ROE:-9.45%
ROA:5.79%
PB:2.46
PE(LYR):-18.84

Loading ...

Owens Corning is Maintained at Hold by Truist Securities

Dow Jones
·
9 hours ago

Owens Corning (OC) Tests The Growth Story Following Its Pullback Is The Stock A Bargain

Simply Wall St.
·
Yesterday

US Stocks on the MOVE-Halozyme, Moderna, Merck

Reuters
·
Yesterday

U.S. Stocks on the MOVE-Halozyme, BKV, AppFolio

Reuters
·
Yesterday

U.S. Stocks on the MOVE-Intel, Vaxcyte, Constellation Brands

Reuters
·
Oct 07

RBC Downgrades Building Product Companies, Flags 2027 Headwinds

Reuters
·
Oct 07

Barclays Sticks to Its Buy Rating for Owens Corning (OC)

TIPRANKS
·
Oct 06

Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer

GlobeNewswire
·
Oct 04

Owens Corning Names Michael J. DeVito to Board

Reuters
·
Sep 29

Vestis Names Russell Tiejema CFO Effective Sept. 28, 2026

Reuters
·
Sep 28

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

GlobeNewswire
·
Sep 28

Press Release: Owens Corning Declares Third-Quarter 2026 Dividend

Dow Jones
·
Sep 18

Owens Corning Elects Michael Devito to Board of Directors

THOMSON REUTERS
·
Sep 17

Owens Corning Adds Ex-Freddie Mac CEO Michael DeVito to Board

Reuters
·
Sep 17

WCLC 2026 | Leads Biolabs’ Opamtistomig (LBL-024) Oral Presentation Demonstrates Robust Response and PFS Benefits in First‑Line NSCLC

GlobeNewswire
·
Sep 14

Owens Corning President, Doors Rachel Barthelemy Marcon Sells 900 Common Shares for $129,663

Reuters
·
Sep 02

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

GlobeNewswire
·
Aug 25

Owens Corning initiated with a Buy at DA Davidson

TIPRANKS
·
Aug 25

Owens Corning Stock And Other Building Materials Names Worth Watching After Tariffs

Simply Wall St.
·
Aug 22

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

GlobeNewswire
·
Aug 20